Primary CNS lymphoma
- Accounts for <5% of brain tumors.
- Invades the brain parenchyma, especially the periventricular regions and superficial brain regions (areas that are in contact with the cerebral ventricles or meninges) and is typically contrast enhancing on imaging.
- Common clinical presentations: encephalopathy/lethargy, headache, focal neurological deficits.
- AIDS is an important risk factor for Primary CNS lymphoma.
- If the patient has both CNS lymphoma and HIV, then Epstein-Barr virus (EBV) will be detectable in the tumor, itself, and in the CSF. These are typically B cell lymphomas. It's believed that the lymphoma results from EBV transformation of activated B cells in the setting of poor T cell defense against the EBV-infected B cells.
- EBV is NEGATIVE in the vast majority (>90%) of immunocompetent patients.
- Histopathology demonstrates diffusely infiltrative atypical (large) lymphocytes in an angiocentric (perivascular) pattern. The cells have prominent nucleoli, frequent mitoses, and scant cytoplasm.
- Radiographically demonstrate enhancing (often intensely) lesions that are more commonly single (less commonly multiple) and are periventricular in location.
- Note that lymphoma responds dramatically to steroids, so it can help with tumor mass but should be avoided PRIOR to biopsy.
- Highly aggressive tumor with poor prognosis: typically < 1 year (often, just several months); 5-year survivial rate: 25 - 45%.
- Immunocompromised hosts have a worse prognosis.
- Treatment:
- Radiation
- Chemotherapy: cytosine, arabinoside, intrathecal methotrexate
- If HIV +, anti-retroviral therapy key to therapy
- Note that CNS lymphoma is almost never indicated because of the deep white matter (typically, periventricular) location of the tumor.
Secondary CNS Lymphoma
- Occurs from CNS invasion of systemic lymphoma
- Accordingly, it more commonly invades the leptomeninges (~2/3 of the time) and only invades the brain parenchyma 1/3 of the time.
- In addition to the leptomeninges, secondary CNS lymphoma infiltrates subependymal regions, accumulates along dura mater, and encases the cranial nerves.
Neuromuscle complications of systemic lymphoma
- Non-Hodgkin lymphoma is associated with inflammatory myopathies: more commonly with dermatomyositis but also with polymyositis.
- Adesina, Adekunle M., Tarik Tihan, Christine E. Fuller, and Tina Young Poussaint. Atlas of Pediatric Brain Tumors. Springer, 2016.
- Aki, Hilal, Didem Uzunaslan, Caner Saygin, Sebnem Batur, Nukhet Tuzuner, Ali Kafadar, Seniz Ongoren, and Buge Oz. “Primary Central Nervous System Lymphoma in Immunocompetent Individuals: A Single Center Experience.” International Journal of Clinical and Experimental Pathology 6, no. 6 (May 15, 2013): 1068–75.
- Gray, Frangoise, Charles Duyckaerts, and Umberto De Girolami. Escourolle and Poirier’s Manual of Basic Neuropathology. OUP USA, 2013.
- Haldorsen, et. al. Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging. American Journal of Neuroradiology. 2010.
- Mansour, et. al. MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging201414:22
DOI: 10.1186/1470-7330-14-22© Mansour et al.; licensee BioMed Central Ltd. 2014
- Newton, Herbert B. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Academic Press, 2018.
- Perry, Arie. “WHO’s Arrived in 2016! An Updated Weather Forecast for Integrated Brain Tumor Diagnosis.” Brain Tumor Pathology 33, no. 3 (July 1, 2016): 157–60. https://doi.org/10.1007/s10014-016-0266-4.
- Prayson, Richard A., and Mark L. Cohen. Practical Differential Diagnosis in Surgical Neuropathology. Springer Science & Business Media, 2000.
Image Reference
- Histopathological Slide
- Histopathologic Image of CNS B-Cell Lymphoma. Stereotactic Biopsy. H & E Stain. January 20, 2006. No machine-readable source provided. Own work assumed (based on copyright claims). KGH assumed. https://commons.wikimedia.org/wiki/File:CNS_lymphoma_(1)_B-cell_type.jpg.